chr2-166280401-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001365536.1(SCN9A):c.2299C>A(p.Pro767Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,589,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P767Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | c.2299C>A | p.Pro767Thr | missense_variant | Exon 14 of 27 | ENST00000642356.2 | NP_001352465.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | c.2299C>A | p.Pro767Thr | missense_variant | Exon 14 of 27 | NM_001365536.1 | ENSP00000495601.1 | |||
| SCN9A | ENST00000303354.11 | c.2299C>A | p.Pro767Thr | missense_variant | Exon 14 of 27 | 5 | ENSP00000304748.7 | |||
| SCN9A | ENST00000409672.5 | c.2266C>A | p.Pro756Thr | missense_variant | Exon 14 of 27 | 5 | ENSP00000386306.1 | |||
| SCN9A | ENST00000645907.1 | c.2266C>A | p.Pro756Thr | missense_variant | Exon 14 of 27 | ENSP00000495983.1 | ||||
| SCN9A | ENST00000454569.6 | c.2266C>A | p.Pro756Thr | missense_variant | Exon 14 of 15 | 1 | ENSP00000413212.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000281 AC: 6AN: 213872 AF XY: 0.0000262 show subpopulations
GnomAD4 exome AF: 0.0000445 AC: 64AN: 1437050Hom.: 0 Cov.: 30 AF XY: 0.0000449 AC XY: 32AN XY: 712182 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74314 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:5
Reported in two alleles in a cohort of patients with atrioventricular nodal reentry tachycardia (PMID: 29396561); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29396561, 30554136)
Inborn genetic diseases Uncertain:1
The c.2266C>A (p.P756T) alteration is located in exon 14 (coding exon 13) of the SCN9A gene. This alteration results from a C to A substitution at nucleotide position 2266, causing the proline (P) at amino acid position 756 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 756 of the SCN9A protein (p.Pro756Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of SCN9A-related conditions (PMID: 30554136). ClinVar contains an entry for this variant (Variation ID: 451326). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN9A protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Primary erythromelalgia;C1833661:Paroxysmal extreme pain disorder;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A;C3502809:Generalized epilepsy with febrile seizures plus Other:1
Variant interpreted as Uncertain significance and reported on 07-09-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at